Retrospective Cohort Study
Copyright ©The Author(s) 2024.
World J Gastrointest Pharmacol Ther. May 28, 2024; 15(3): 92305
Published online May 28, 2024. doi: 10.4292/wjgpt.v15.i3.92305
Table 2 Association of risk factors and forest classification with outcome variables
VariablesTotal, n (%)Hospital stay in days
Mortality in 7 d
Mortality in 30 d
Re-bleed in 24 h
Re-current bleed in 7 d
≤ 5 (n = 104)
> 5 (n = 38)
No (n = 127)
Yes (n = 15)
No (n = 121)
Yes (n = 21)
No (n = 122)
Yes (n = 20)
No (n = 116)
Yes (n = 26)
Smoking
    Yes31 (21.8)24 (77.4)7 (22.6)29 (93.5)2 (6.5)29 (93.5)2 (6.5)27 (87.1)4 (12.9)26 (83.9)5 (16.1)
    No111 (78.2)80 (72.1)31 (27.9)98 (88.3)13 (11.7)92 (82.9)19 (17.1)95 (85.6)16 (14.4)90 (81.1)21 (18.9)
Steroids
    Yes8 (5.6)7 (87.5)1 (12.5)7 (87.5)1 (12.5)7 (87.5)1 (12.5)7 (87.5)1 (12.5)7 (87.5)1 (12.5)
    No134 (94.4)97 (72.4)37 (27.6)120 (89.6)14 (10.4)114 (85.1)20 (14.9)115 (85.8)19 (14.2)109 (81.3)25 (18.7)
H. pylori
    Yes26 (18.3)20 (76.9)6 (23.1)24 (92.3)2 (7.7)23 (88.5)3 (11.5)22 (84.6)4 (15.4)20 (76.9)6 (23.1)
    No116 (81.7)84 (72.4)32 (27.6)103 (88.8)13 (11.2)98 (84.5)18 (15.5)100 (86.2)16 (13.8)96 (82.8)20 (17.2)
Antiplatele
    Yes47 (33.1)34 (72.3)13 (27.7)37 (78.7)10 (21.3)b36 (76.6)11 (23.4)a37 (78.7)10 (21.3)35 (74.5)12 (25.5)
    No95 (66.9)70 (73.7)25 (26.3)90 (94.7)5 (5.3)85 (89.5)10 (10.5)85 (89.5)10 (10.5)81 (85.3)14 (14.7)
Alternative medications
    Yes56 (39.4)39 (69.6)17 (30.4)47 (83.9)9 (16.1)44 (78.6)12 (21.4)44 (78.6)12 (21.4)a43 (76.8)13 (23.2)
    No86 (60.6)65 (75.6)21 (24.4)80 (93.0)6 (7.0)77 (89.5)9 (10.5)78 (90.7)8 (9.3)73 (84.9)13 (15.1)
Forrest classification
    I18 (12.7)10 (55.6)8 (44.4)18 (100.0)017 (94.4)1 (5.6)13 (72.2)5 (27.8)11 (61.1)7 (38.9)a
    II21 (14.8)14 (66.7)7 (33.3)18 (85.7)3 (14.3)17 (81.0)4 (19.0)17 (81.0)4 (19.0)16 (76.2)5 (23.8)
    III103 (72.5)80 (77.7)23 (22.3)91 (88.3)12 (11.7)87 (84.5)16 (15.5)92 (89.3)11 (10.7)89 (86.4)14 (13.6)